This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2011 Apr:106 Suppl 1:S2-25; quiz S26.

doi: 10.1038/ajg.2011.58.

An evidence-based systematic review on medical therapies for inflammatory bowel disease

Nicholas J Talley¹, Maria T Abreu, Jean-Paul Achkar, Charles N Bernstein, Marla C Dubinsky, Stephen B Hanauer, Sunanda V Kane, William J Sandborn, Thomas A Ullman, Paul Moayyedi; American College of Gastroenterology IBD Task Force

Affiliations

PMID: 21472012
DOI: 10.1038/ajg.2011.58

Review

An evidence-based systematic review on medical therapies for inflammatory bowel disease

Nicholas J Talley et al. Am J Gastroenterol. 2011 Apr.

. 2011 Apr:106 Suppl 1:S2-25; quiz S26.

doi: 10.1038/ajg.2011.58.

Authors

Nicholas J Talley¹, Maria T Abreu, Jean-Paul Achkar, Charles N Bernstein, Marla C Dubinsky, Stephen B Hanauer, Sunanda V Kane, William J Sandborn, Thomas A Ullman, Paul Moayyedi; American College of Gastroenterology IBD Task Force

Affiliation

¹ Department of Medicine, Faculty of Health, University of Newcastle, Callaghan, NSW 2308, Australia. Nicholas.Talley@newcastle.edu.au

PMID: 21472012
DOI: 10.1038/ajg.2011.58

No abstract available

PubMed Disclaimer

Similar articles

Drugs for inflammatory bowel disease.
[No authors listed] [No authors listed] Treat Guidel Med Lett. 2009 Sep;7(85):65-74; quiz 75-6. Treat Guidel Med Lett. 2009. PMID: 19696709 Review. No abstract available.
[Therapy of chronic inflammatory bowel diseases].
Stange EF. Stange EF. Praxis (Bern 1994). 2002 Nov 20;91(47):2029-39. doi: 10.1024/0369-8394.91.47.2029. Praxis (Bern 1994). 2002. PMID: 12501498 Review. German.
[Chronic inflammatory bowel diseases. Update on evidence-based therapy].
[No authors listed] [No authors listed] MMW Fortschr Med. 2005 Apr 28;147(17):58-9. MMW Fortschr Med. 2005. PMID: 15903063 German. No abstract available.
[Inflammatory bowel disease].
Patuto N, Beglinger C. Patuto N, et al. Praxis (Bern 1994). 2013 Aug 21;102(17):1046-52. doi: 10.1024/1661-8157/a001380. Praxis (Bern 1994). 2013. PMID: 23965717 Review. German.
Methotrexate for inflammatory bowel disease: time for reconsideration.
Nielsen OH, Ainsworth MA, Steenholdt C. Nielsen OH, et al. Expert Rev Gastroenterol Hepatol. 2019 May;13(5):407-409. doi: 10.1080/17474124.2019.1596797. Epub 2019 Mar 21. Expert Rev Gastroenterol Hepatol. 2019. PMID: 30895827 No abstract available.

See all similar articles

Cited by

Management of ulcerative colitis in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease updated in 2023.
Yen HH, Wu JF, Wang HY, Chang TA, Chang CH, Chang CW, Chao TH, Chou JW, Chou YH, Chuang CH, Hsu WH, Hsu TC, Huang TY, Hung TI, Le PH, Lin CC, Lin CC, Lin CP, Lin JK, Lin WC, Ni YH, Shieh MJ, Shih IL, Shun CT, Tsai TJ, Wang CY, Weng MT, Wong JM, Wu DC, Wei SC. Yen HH, et al. Intest Res. 2024 Jul;22(3):213-249. doi: 10.5217/ir.2023.00050. Epub 2024 Jul 29. Intest Res. 2024. PMID: 39099217 Free PMC article.
Pharmaceutical Potential of Remedial Plants and Helminths for Treating Inflammatory Bowel Disease.
Jamtsho T, Loukas A, Wangchuk P. Jamtsho T, et al. Pharmaceuticals (Basel). 2024 Jun 21;17(7):819. doi: 10.3390/ph17070819. Pharmaceuticals (Basel). 2024. PMID: 39065669 Free PMC article. Review.
Therapeutic Potential of Essential Oils Against Ulcerative Colitis: A Review.
Li J, Zhang X, Luan F, Duan J, Zou J, Sun J, Shi Y, Guo D, Wang C, Wang X. Li J, et al. J Inflamm Res. 2024 May 31;17:3527-3549. doi: 10.2147/JIR.S461466. eCollection 2024. J Inflamm Res. 2024. PMID: 38836243 Free PMC article. Review.
Outcomes of Budesonide as a Treatment Option for Immune Checkpoint Inhibitor-Related Colitis in Patients with Cancer.
Machado AP, Shaikh AS, Saji A, Shatila M, Oliva IG, Wang Y, Shirwaikar Thomas A. Machado AP, et al. Cancers (Basel). 2024 May 18;16(10):1919. doi: 10.3390/cancers16101919. Cancers (Basel). 2024. PMID: 38791997 Free PMC article.
Improving Medication Adherence Levels in Inflammatory Bowel Disease (IBD) Patients: A Narrative Evidence-Based Review.
Amiesimaka OI, Aluzaite K, Braund R, Schultz M. Amiesimaka OI, et al. Patient Prefer Adherence. 2024 Apr 20;18:905-916. doi: 10.2147/PPA.S383304. eCollection 2024. Patient Prefer Adherence. 2024. PMID: 38660627 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wolters Kluwer
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information